We follow a true partnership model.

Our relationships with our portfolio business owners are based on respect and a common goal to accelerate growth to build shareholder value.

We manage five funds with over $1.3 billion assets under management.* Our investors are comprised of large corporate pension plans, insurance companies, foundations, fund of fund managers, high net worth family trusts and endowments.

Our extensive knowledge of the healthcare market allows us to quickly evaluate and complete a deal. Having owned and operated our own healthcare businesses, we understand the operational and strategic issues confronting business owners, and can act as a valuable strategic resource.

*As of 12/31/2022




$1.3 billion*


We seek to partner with best-in-class mid-to-late-stage companies seeking growth capital, strategic guidance, and acquisition expertise. We look for opportunities to invest in companies that deliver high quality services or products and have the potential to reduce costs for payors.


We demonstrate flexibility when structuring transactions, and when catering to an owner’s goals post-closing. We prefer partnering with management teams, but have the bench strength to deploy executives in buyout situations, when owners seek full liquidity.

We prefer to purchase a controlling interest in transactions, but have the ability to invest in minority transactions as well.


Our key focus is our orientation toward growth, whether it be through organic initiatives or via strategic acquisitions. This focus also impacts the way we capitalize businesses, as we avoid the burden of undue leverage.

We generate returns by working with management teams to grow businesses and not by handcuffing growth with excessive debt.


DW Healthcare Partners invests exclusively in healthcare companies. Our investment team’s breadth of knowledge and operational experience across multiple sectors of healthcare allows us greater insight into the challenges facing our partners today.

We believe this investment focus allows us to better understand and monitor the regulatory climate, pending and current reimbursement issues, and government policies and trends that impact the healthcare marketplace. This knowledge is valuable as it enables an expeditious due diligence process.

Our deal origination team develops and maintains relationships with thousands of business owners and identifies hundreds of potential investment opportunities annually. We actively pursue add-on acquisition opportunities for our partners which, in our experience, has proven to accelerate growth in many competitive markets.



$3-5 million EBITDA for Founders Fund
$6 million EBITDA and up for Main Fund


North America


Majority ownership


$20-60 million